Skip to main content

Table 1 Seroprevalence of anti-SARS-CoV-2 RBD IgG antibodies by participant (n = 1997) characteristics and hospitals, Ethiopia, 2021

From: High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

Characteristics

N

%

Seroprevalence (%), 95% CI

Gender

   

 Male

980

49.3

39.6 (36.6–42.7)

 Female

 

51.7

42.37 (39.4–45.5)

Age (in years)

   

 19–24

169

8.8

44.0 (36.7–51.7)

 25–34

918

46.0

41.6 (38.4–44.8)

 35–49

792

39.7

39.7 (36.4–43.0)

 ≥ 50

115

5.8

41.7 (33.00–51.0)

Morbidity

   

 Yes

133

6.7

44.4 (36.1–52.9)

 No

1864

93.3

40.9 (38.7–43.3)

COVID-19

   

 Symptomatic

507

26.0

39.9 (37.4–42.4)

 Asymptomatic

1490

74.0

45.2 (40.9–49.5)

Contact

   

 Yes

557

29.0

48.5 (44.3–52.6)

 No

1362

71.0

38.1 (35.6–40.7)

Hospitals

   

 ALRET

308

15.4

48.1 (40.3–53.6)

 Hawassa

414

20.7

44.8 (40.05–49.)

 Gondar

453

22.6

44.7 (40.12–49.3)

 Asella

484

24.2

40.7 (36.4–45.1)

 Hiwot Fana

338

17.0

24.6 (20.3–29.4)

Occupation

   

 Doctor

368

18.7

40.5 (35.6–45.6)

 Nurse

559

28.3

41.9 (37.7–45.8)

 Lab Technician

223

11.3

46.2 (39.7–52.8)

 Administrator

345

17.4

39.1 (34.1–44.4)

 Others

478

24.2

43.5 (38.7–48.4)

  1. N is the total number of participants included in each category
  2. % indicates proportion of participants that fell within each category